202 related articles for article (PubMed ID: 30003388)
1. NCAM Mimetic Peptides: Potential Therapeutic Target for Neurological Disorders.
Chu C; Gao Y; Lan X; Thomas A; Li S
Neurochem Res; 2018 Sep; 43(9):1714-1722. PubMed ID: 30003388
[TBL] [Abstract][Full Text] [Related]
2. Triple effect of mimetic peptides interfering with neural cell adhesion molecule homophilic cis interactions.
Li S; Kolkova K; Rudenko O; Soroka V; Poulsen FM; Bock E; Berezin V
Biochemistry; 2005 Apr; 44(13):5034-40. PubMed ID: 15794641
[TBL] [Abstract][Full Text] [Related]
3. A peptide mimetic targeting trans-homophilic NCAM binding sites promotes spatial learning and neural plasticity in the hippocampus.
Kraev I; Henneberger C; Rossetti C; Conboy L; Kohler LB; Fantin M; Jennings A; Venero C; Popov V; Rusakov D; Stewart MG; Bock E; Berezin V; Sandi C
PLoS One; 2011; 6(8):e23433. PubMed ID: 21887252
[TBL] [Abstract][Full Text] [Related]
4. An NCAM-derived FGF-receptor agonist, the FGL-peptide, induces neurite outgrowth and neuronal survival in primary rat neurons.
Neiiendam JL; Køhler LB; Christensen C; Li S; Pedersen MV; Ditlevsen DK; Kornum MK; Kiselyov VV; Berezin V; Bock E
J Neurochem; 2004 Nov; 91(4):920-35. PubMed ID: 15525346
[TBL] [Abstract][Full Text] [Related]
5. A peptide derived from a trans-homophilic binding site in neural cell adhesion molecule induces neurite outgrowth and neuronal survival.
Køhler LB; Soroka V; Korshunova I; Berezin V; Bock E
J Neurosci Res; 2010 Aug; 88(10):2165-76. PubMed ID: 20209630
[TBL] [Abstract][Full Text] [Related]
6. The synthetic NCAM mimetic peptide FGL mobilizes neural stem cells in vitro and in vivo.
Klein R; Blaschke S; Neumaier B; Endepols H; Graf R; Keuters M; Hucklenbroich J; Albrechtsen M; Rees S; Fink GR; Schroeter M; Rueger MA
Stem Cell Rev Rep; 2014 Aug; 10(4):539-47. PubMed ID: 24817672
[TBL] [Abstract][Full Text] [Related]
7. NCAM-mimetic, FGL peptide, restores disrupted fibroblast growth factor receptor (FGFR) phosphorylation and FGFR mediated signaling in neural cell adhesion molecule (NCAM)-deficient mice.
Aonurm-Helm A; Berezin V; Bock E; Zharkovsky A
Brain Res; 2010 Jan; 1309():1-8. PubMed ID: 19909731
[TBL] [Abstract][Full Text] [Related]
8. A synthetic peptide ligand of neural cell adhesion molecule (NCAM), C3d, promotes neuritogenesis and synaptogenesis and modulates presynaptic function in primary cultures of rat hippocampal neurons.
Kiryushko D; Kofoed T; Skladchikova G; Holm A; Berezin V; Bock E
J Biol Chem; 2003 Apr; 278(14):12325-34. PubMed ID: 12502709
[TBL] [Abstract][Full Text] [Related]
9. Neural cell adhesion molecule peptide mimetics modulate emotionality: pharmacokinetic and behavioral studies in rats and non-human primates.
Turner CA; Lyons DM; Buckmaster CL; Aurbach EL; Watson SJ; Schatzberg AF; Akil H
Neuropsychopharmacology; 2019 Jan; 44(2):356-363. PubMed ID: 29703997
[TBL] [Abstract][Full Text] [Related]
10. Dennexin peptides modeled after the homophilic binding sites of the neural cell adhesion molecule (NCAM) promote neuronal survival, modify cell adhesion and impair spatial learning.
Køhler LB; Christensen C; Rossetti C; Fantin M; Sandi C; Bock E; Berezin V
Eur J Cell Biol; 2010 Nov; 89(11):817-27. PubMed ID: 20692716
[TBL] [Abstract][Full Text] [Related]
11. Extracellular adenosine triphosphate affects neural cell adhesion molecule (NCAM)-mediated cell adhesion and neurite outgrowth.
Skladchikova G; Ronn LC; Berezin V; Bock E
J Neurosci Res; 1999 Jul; 57(2):207-18. PubMed ID: 10398298
[TBL] [Abstract][Full Text] [Related]
12. Pharmacological approach for targeting dysfunctional brain plasticity: Focus on neural cell adhesion molecule (NCAM).
Aonurm-Helm A; Jaako K; Jürgenson M; Zharkovsky A
Pharmacol Res; 2016 Nov; 113(Pt B):731-738. PubMed ID: 27095082
[TBL] [Abstract][Full Text] [Related]
13. NCAM mimetic peptides: Pharmacological and therapeutic potential.
Berezin V; Bock E
J Mol Neurosci; 2004; 22(1-2):33-39. PubMed ID: 14742908
[TBL] [Abstract][Full Text] [Related]
14. Depression-like behaviour in neural cell adhesion molecule (NCAM)-deficient mice and its reversal by an NCAM-derived peptide, FGL.
Aonurm-Helm A; Jurgenson M; Zharkovsky T; Sonn K; Berezin V; Bock E; Zharkovsky A
Eur J Neurosci; 2008 Oct; 28(8):1618-28. PubMed ID: 18973581
[TBL] [Abstract][Full Text] [Related]
15. Zippers make signals: NCAM-mediated molecular interactions and signal transduction.
Walmod PS; Kolkova K; Berezin V; Bock E
Neurochem Res; 2004 Nov; 29(11):2015-35. PubMed ID: 15662836
[TBL] [Abstract][Full Text] [Related]
16. Identification of NCAM-binding peptides promoting neurite outgrowth via a heterotrimeric G-protein-coupled pathway.
Hansen RK; Christensen C; Korshunova I; Kriebel M; Burkarth N; Kiselyov VV; Olsen M; Ostergaard S; Holm A; Volkmer H; Walmod PS; Berezin V; Bock E
J Neurochem; 2007 Nov; 103(4):1396-407. PubMed ID: 17854387
[TBL] [Abstract][Full Text] [Related]
17. Insight into the structural mechanism of the bi-modal action of an NCAM mimetic, the C3 peptide.
Kiselyov VV; Li S; Berezin V; Bock E
Neurosci Lett; 2009 Mar; 452(3):224-7. PubMed ID: 19348728
[TBL] [Abstract][Full Text] [Related]
18. Neural cell adhesion molecule induces intracellular signaling via multiple mechanisms of Ca2+ homeostasis.
Kiryushko D; Korshunova I; Berezin V; Bock E
Mol Biol Cell; 2006 May; 17(5):2278-86. PubMed ID: 16510522
[TBL] [Abstract][Full Text] [Related]
19. WITHDRAWN: Dendritic Spine and Synapse Morphological Alterations Induced by a Neural Cell Adhesion Molecule (NCAM) Mimetic.
Stewart M; Popov V; Medvedev N; Gabbott P; Corbett N; Kraev I; Davies H
Neurochem Res; 2008 Mar; ():. PubMed ID: 18338259
[TBL] [Abstract][Full Text] [Related]
20. Neuritogenic and neuroprotective properties of peptide agonists of the fibroblast growth factor receptor.
Li S; Bock E; Berezin V
Int J Mol Sci; 2010 May; 11(6):2291-305. PubMed ID: 20640153
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
